Literature DB >> 24115552

Draft Genome Sequence of a Mucoid Isolate of Pseudomonas aeruginosa Strain C7447m from a Patient with Cystic Fibrosis.

Yeshi Yin1, T Ryan Withers, Shannon L Johnson, Hongwei D Yu.   

Abstract

Alginate overproduction by Pseudomonas aeruginosa, or mucoidy, plays an important role in the pathogenesis of chronic lung infections in cystic fibrosis (CF) patients. Here we report the draft genome sequence of a clinical isolate of mucoid P. aeruginosa strain C7447m from a CF patient with chronic lung infection.

Entities:  

Year:  2013        PMID: 24115552      PMCID: PMC3795222          DOI: 10.1128/genomeA.00837-13

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Overproduction of the capsular polysaccharide alginate by the Gram-negative bacterium Pseudomonas aeruginosa is a hallmark of chronic lung infections in cystic fibrosis (CF) patients. Among its many roles in virulence, alginate protects the bacteria from host defenses (1) and antibiotic chemotherapy (2). Here, we report the genome sequence of a clinical alginate-overproducing, mucoid P. aeruginosa isolate, C7447m. Strain C7447m was originally isolated from a CF patient in 1997 by David P. Speert in Vancouver, British Columbia, Canada. Genomic DNA extracted by cetyltrimethylammonium bromide (CTAB)-NaCl and phenol-chloroform-isoamyl alcohol was sent to Cofactor Genomics (St. Louis, MO). Paired-end sequencing libraries were generated according to vendor protocols (Illumina, San Diego, CA). The genome sequencing was performed on an Illumina GAIIX. Totals of 11,770,660 raw reads and 1,883,305,600 bp were obtained. The sequence data were generated and assembled using Illumina Pipeline version SCS 2.8.0 based on paired-end tags with OLB 1.8.0. The sequences were then aligned and annotated according to the reference strain PAO1 genome (GenBank accession no. NC_2516.2) by use of the Novocraft novoAlign v 2.07.13 software package. Further analysis of the genome was performed using Samtools version 01.15c for the generation of pileup after sorting and the removal of duplicate reads. The analysis pipeline software was developed by CoFactor Genomics, and all specifics regarding aligner algorithms can be obtained from Novocraft Technologies. In summary, the number of generated base pairs resulted in approximately 224× coverage of the reference PAO1 genome. The number of base pairs saturated at or above 8× is 6,088,140 (97.19%), and the number of base pairs saturated below 8× is 176,264 (2.81%). The genome was annotated and prepared for submission using Ergatis-based workflow with manual correction. The analysis results of single nucleotide polymorphisms (SNPs) and indels showed that 643 heterozygous mutants (255 indels and 388 SNPs; count ratios of ≥0.4 and ≤0.6) and 25,753 homozygous SNPs (count ratio, >0.6) were found. The count ratio is defined as the number of times the reference base is observed divided by the coverage at this base (counting all matches and mismatches). Only 14 indels, with coverage at the site above 8× and the mutant to wild type ratios at >2, were included in this genome edition. Thirteen of the included indels were distributed in the intergenic region. Among the homozygous SNPs, 22,439 mutations were distributed in 4,516 genes/coding sequence (CDS) (which accounts for 79.47% of the total genes/CDS), and 3,314 mutations were identified in the intergenic region. Most of the mutant genes have multiple SNPs, and 2,846 genes/CDS have 3 or more homozygous SNPs. Despite the mucoid phenotype, the strain C7447m has wild-type algU and mucA. Furthermore, among previously reported alginate production-related genes (3–6), the amino acid sequences of MucC, MucD, AlgL, and KinB each have 1 amino acid change; AlgX has 2 amino acid changes; and AlgI and AlgP have 5 amino acid changes. We also found some SNPs located in the intergenic region before algB, algC, algD, amrZ, clpP2, mucE, mucR, and pilA.

Nucleotide sequence accession number.

The draft genome sequence of C7447m has been deposited in GenBank with the accession number CP006728.
  5 in total

1.  The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gamma-mediated macrophage killing.

Authors:  Jeff G Leid; Carey J Willson; Mark E Shirtliff; Daniel J Hassett; Matthew R Parsek; Alyssa K Jeffers
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

Review 2.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

Authors:  J R Govan; V Deretic
Journal:  Microbiol Rev       Date:  1996-09

3.  ClpXP proteases positively regulate alginate overexpression and mucoid conversion in Pseudomonas aeruginosa.

Authors:  Dongru Qiu; Vonya M Eisinger; Nathan E Head; Gerald B Pier; Hongwei D Yu
Journal:  Microbiology       Date:  2008-07       Impact factor: 2.777

4.  The Pseudomonas aeruginosa sensor kinase KinB negatively controls alginate production through AlgW-dependent MucA proteolysis.

Authors:  F Heath Damron; Dongru Qiu; Hongwei D Yu
Journal:  J Bacteriol       Date:  2009-01-23       Impact factor: 3.490

5.  Truncation of type IV pilin induces mucoidy in Pseudomonas aeruginosa strain PAO579.

Authors:  T Ryan Withers; F Heath Damron; Yeshi Yin; Hongwei D Yu
Journal:  Microbiologyopen       Date:  2013-03-27       Impact factor: 3.139

  5 in total
  3 in total

1.  Pyrimidine Biosynthesis Regulates the Small-Colony Variant and Mucoidy in Pseudomonas aeruginosa through Sigma Factor Competition.

Authors:  Roy Al Ahmar; Brandon D Kirby; Hongwei D Yu
Journal:  J Bacteriol       Date:  2018-12-07       Impact factor: 3.490

2.  Identification of Novel Genomic Islands in Liverpool Epidemic Strain of Pseudomonas aeruginosa Using Segmentation and Clustering.

Authors:  Mehul Jani; Kalai Mathee; Rajeev K Azad
Journal:  Front Microbiol       Date:  2016-08-03       Impact factor: 5.640

3.  Genome sequence of Pseudomonas aeruginosa PAO1161, a PAO1 derivative with the ICEPae1161 integrative and conjugative element.

Authors:  Adam Kawalek; Karolina Kotecka; Magdalena Modrzejewska; Jan Gawor; Grazyna Jagura-Burdzy; Aneta Agnieszka Bartosik
Journal:  BMC Genomics       Date:  2020-01-06       Impact factor: 3.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.